Advertisement

Ads Placeholder
Loading...

Healios K.K.

HLOSF•PNK
Healthcare
Biotechnology
$2.30
$0.10(4.55%)
U.S. Market opens in 5h 2m

Healios K.K. (HLOSF) Stock Overview

Explore Healios K.K.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap247.6M
P/E Ratio-16.91
EPS (TTM)$-0.17
ROE-0.80%
Fundamental Analysis

AI Price Forecasts

1 Month$2.30
3 Months$2.75
1 Year Target$3.74

HLOSF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Healios K.K. (HLOSF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 40.64, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $3.74.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -16.91 and a market capitalization of 247.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
4.55%
5-Day Change
4.55%
1-Month Change
-16.36%
3-Month Change
19.17%
6-Month Change
-34.29%
Year-to-Date (YTD) Change
19.17%
1-Year Change
18.56%
3-Year Change
-84.19%
5-Year Change
-87.11%
All-Time (Max) Change
-87.57%

Contact Information

https://www.healios.co.jp
NaN
Yurakucho Denki Building, Tokyo, NaN, 100-0006

Company Facts

650 Employees
IPO DateNov 9, 2020
CountryJP
Actively Trading

Frequently Asked Questions